Print

Purpose

The aim of the present study is to investigate a plasma exosome RNA signature to diagnose clinically significant prostate cancer.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Blood prostate-specific antigen PSA>4ng/dl; 2. Patients suspected of having prostate cancer through clinical symptoms, digital rectal examination, ultrasound examination, magnetic resonance imaging. 3. The patient is willing to undergo prostate biopsy.

Exclusion Criteria

  1. Previous diagnosis of prostate cancer through prostate biopsy; 2. History of other malignant tumors in the past two years; 3. According to the research physician''s judgment, serious complications may occur and affect the normal conduct of the experiment

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Study Cohort The experimental arm receiving diagnosis from serum RNA combination

Recruiting Locations

Northwestern Memorial Hospital
Chicago, Illinois 60611
Contact:
Qiang Zhang, MD.
+1 312 503 2891
q-zhang2@northwestern.edu

More Details

Status
Recruiting
Sponsor
Xijing Hospital

Study Contact

Jianhua Jiao, MD.
+86 029 84771062
1531769428@qq.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.